![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 11, 7094-7100, Jun, 1984
RV Farese, DE Barnes, JS Davis, ML Standaert and RJ Pollet
BC3H-1 myocytes were cultured with 32PO4 for 3 days to label phospholipids
to constant specific activity. Subsequent treatment with physiological
concentrations of insulin provoked 40-70% increases in 32PO4 levels
(reflecting increases in mass) in phosphatidic acid, phosphatidylinositol,
and polyphosphoinositides, and, lesser, 20-25% increases in
phosphatidylserine and the combined chromatographic area containing
phosphatidylethanolamine plus phosphatidylcholine plus phosphatidylcholine.
Insulin-induced increases in phospholipids were significant within 5 min
and near-maximal at 15-30 min. Comparable rapid insulin-induced increases
in [3H]phosphatidylinositol were observed in myocytes prelabeled with
[3H]inositol. These insulin effects (as per prolonged pulse-chase
experiments) were due to increase phospholipid synthesis rather than
decreased phospholipid degradation. Cycloheximide (and puromycin)
pretreatment prevented insulin-induced increases in phospholipids and
rapidly reversed ongoing insulin effects on phospholipids and pyruvate
dehydrogenase activity. Insulin also rapidly increased diacylglycerol
levels. These findings suggest that: (a) insulin provokes rapid increases
in de novo synthesis of phosphatidic acid and its derivatives, e.g.
phosphoinositides and diacylglycerol; (b) protein synthesis inhibitors
diminish phospholipid levels in insulin-treated (but not control) tissues
by increasing phospholipid degradation (?phospholipase(s) activation); and
(c) changes in phospholipids and diacylglycerol may be important for
changes in pyruvate dehydrogenase and other enzymatic activities during
treatment with insulin and/or protein synthesis inhibitors.
Effects of insulin and protein synthesis inhibitors on phospholipid metabolism, diacylglycerol levels, and pyruvate dehydrogenase activity in BC3H-1 cultured myocytes
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. V. Farese Insulin-Sensitive Phospholipid Signaling Systems and Glucose Transport. Update II Experimental Biology and Medicine, April 1, 2001; 226(4): 283 - 295. [Abstract] [Full Text] |
||||
![]() |
M. L. Standaert, L. Galloway, P. Karnam, G. Bandyopadhyay, J. Moscat, and R. V. Farese Protein Kinase C-zeta as a Downstream Effector of Phosphatidylinositol 3-Kinase during Insulin Stimulation in Rat Adipocytes. POTENTIAL ROLE IN GLUCOSE TRANSPORT J. Biol. Chem., November 28, 1997; 272(48): 30075 - 30082. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schubert, K. Carel, D. DePaolo, W. Leitner, and B. Draznin Interactions of Protein Kinase C with Insulin Signaling. INFLUENCE ON GAP AND SOS ACTIVITIES J. Biol. Chem., June 28, 1996; 271(26): 15311 - 15314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Farese, T. Konda, J. Davis, M. Standaert, R. Pollet, and D. Cooper Insulin rapidly increases diacylglycerol by activating de novo phosphatidic acid synthesis Science, May 1, 1987; 236(4801): 586 - 589. [Abstract] [PDF] |
||||
![]() |
A. Saltiel, J. Fox, P Sherline, and P Cuatrecasas Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase Science, August 29, 1986; 233(4767): 967 - 972. [Abstract] [PDF] |
||||
![]() |
L. Fleischman, S. Chahwala, and L Cantley ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites Science, January 24, 1986; 231(4736): 407 - 410. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |